Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036
DCC-2036 开关控制抑制剂对 BCR-ABL1 酪氨酸激酶（包括门控 T315I 突变体）的构象控制抑制作用
期刊:Cancer Cell
影响因子:44.5
doi:10.1016/j.ccr.2011.03.003
Chan, Wayne W; Wise, Scott C; Kaufman, Michael D; Ahn, Yu Mi; Ensinger, Carol L; Haack, Torsten; Hood, Molly M; Jones, Jennifer; Lord, John W; Lu, Wei Ping; Miller, David; Patt, William C; Smith, Bryan D; Petillo, Peter A; Rutkoski, Thomas J; Telikepalli, Hanumaiah; Vogeti, Lakshminarayana; Yao, Tony; Chun, Lawrence; Clark, Robin; Evangelista, Peter; Gavrilescu, L Cristina; Lazarides, Katherine; Zaleskas, Virginia M; Stewart, Lance J; Van Etten, Richard A; Flynn, Daniel L
